ATE522546T1 - Verfahren zum nachweis von probnp mit einem monoklonalen antikörper, der die amino saüre 38- 43 bindet - Google Patents

Verfahren zum nachweis von probnp mit einem monoklonalen antikörper, der die amino saüre 38- 43 bindet

Info

Publication number
ATE522546T1
ATE522546T1 AT04732278T AT04732278T ATE522546T1 AT E522546 T1 ATE522546 T1 AT E522546T1 AT 04732278 T AT04732278 T AT 04732278T AT 04732278 T AT04732278 T AT 04732278T AT E522546 T1 ATE522546 T1 AT E522546T1
Authority
AT
Austria
Prior art keywords
amino acid
monoclonal antibodies
probnp
native probnp
binds amino
Prior art date
Application number
AT04732278T
Other languages
English (en)
Inventor
Volker Klemt
Anneliese Borgya
Andreas Gallusser
Michael Grol
Klaus Hallermayer
Christoph Seidel
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33427054&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE522546(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE522546T1 publication Critical patent/ATE522546T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/58Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • C12N5/12Fused cells, e.g. hybridomas
    • C12N5/16Animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT04732278T 2003-05-12 2004-05-12 Verfahren zum nachweis von probnp mit einem monoklonalen antikörper, der die amino saüre 38- 43 bindet ATE522546T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03010591 2003-05-12
PCT/EP2004/005091 WO2004099252A1 (en) 2003-05-12 2004-05-12 Method of detecting native probnp with amonoclonal antibody binding to the amino acids 38-44

Publications (1)

Publication Number Publication Date
ATE522546T1 true ATE522546T1 (de) 2011-09-15

Family

ID=33427054

Family Applications (2)

Application Number Title Priority Date Filing Date
AT04732278T ATE522546T1 (de) 2003-05-12 2004-05-12 Verfahren zum nachweis von probnp mit einem monoklonalen antikörper, der die amino saüre 38- 43 bindet
AT04732282T ATE517124T1 (de) 2003-05-12 2004-05-12 Verfahren zum nachweis von probnp mit einem monoklonalen antikörper, der die amino saüre 42- 46 bindet

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT04732282T ATE517124T1 (de) 2003-05-12 2004-05-12 Verfahren zum nachweis von probnp mit einem monoklonalen antikörper, der die amino saüre 42- 46 bindet

Country Status (16)

Country Link
US (4) US7264938B2 (de)
EP (4) EP1625164B1 (de)
JP (4) JP4430066B2 (de)
KR (2) KR20080011467A (de)
CN (3) CN100497393C (de)
AT (2) ATE522546T1 (de)
AU (1) AU2004235974B2 (de)
BR (1) BRPI0410261B8 (de)
CA (2) CA2522747C (de)
DK (3) DK2256132T3 (de)
ES (3) ES2372282T3 (de)
HK (1) HK1097855A1 (de)
HU (1) HUE025169T2 (de)
MX (1) MXPA05011826A (de)
PL (3) PL2256132T3 (de)
WO (2) WO2004099252A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2843396B1 (fr) * 2002-08-07 2005-04-15 Bio Rad Pasteur Anticorps specifiques pour le diagnostic de l'insuffisance cardiaque
ATE522546T1 (de) * 2003-05-12 2011-09-15 Hoffmann La Roche Verfahren zum nachweis von probnp mit einem monoklonalen antikörper, der die amino saüre 38- 43 bindet
WO2004105575A2 (en) * 2003-05-29 2004-12-09 Trustee Of Darmouth College A method for detecting cardiac ischemia via changes in b-natriuretic peptide levels
DE10355731A1 (de) 2003-11-28 2005-06-30 Roche Diagnostics Gmbh Analytischer Sandwichtest zur Bestimmung von NT-proBNP
ES2288718T3 (es) * 2004-07-07 2008-01-16 F. Hoffmann-La Roche Ag Panel de multiples marcadores para la diabetes de tipo 1 y de tipo 2.
AT500800B1 (de) * 2004-09-08 2008-07-15 Biomedica Medizinprodukte Gmbh Verfahren zur bestimmung von probnp
JP2010517023A (ja) 2007-01-25 2010-05-20 エフ.ホフマン−ラ ロシュ アーゲー 心不全の評価におけるigfbp−7の使用
KR100836322B1 (ko) * 2007-08-31 2008-06-09 현대자동차주식회사 차량용 흡음재 제작장치 및 방법
US9482677B2 (en) 2008-02-27 2016-11-01 Scios Inc. Method, composition and device for sampling natriuretic peptides in a biological fluid
CN102027374A (zh) 2008-04-30 2011-04-20 霍夫曼-拉罗奇有限公司 Sfrp-3在评价心力衰竭中的用途
CN102549436A (zh) 2009-07-27 2012-07-04 霍夫曼-拉罗奇有限公司 mimecan在评价心力衰竭中的用途
JP5728488B2 (ja) * 2009-11-13 2015-06-03 ビージー メディシン, インコーポレイテッド 心筋梗塞のリスクファクターおよび予測
CA2807240A1 (en) 2010-08-04 2012-02-09 Idexx Laboratories, Inc. Detection of degradation products of canine nt-probnp
AU2012262154B2 (en) 2011-05-31 2016-08-04 Idexx Laboratories, Inc. Detection of degradation products of feline NT-proBNP
WO2013042603A1 (ja) * 2011-09-20 2013-03-28 コニカミノルタホールディングス株式会社 検体希釈用液、それを用いたキットおよび蛍光測定方法
US20140273273A1 (en) 2012-11-01 2014-09-18 Christie Mitchell Ballantyne Biomarkers to improve prediction of heart failure risk
CN103304665A (zh) * 2013-05-21 2013-09-18 上海贝西生物科技有限公司 一种抗氨基末端脑利钠肽前体单克隆抗体及其应用
SG11201702490PA (en) 2014-10-10 2017-04-27 Akira Matsumori Method for detecting cardiac failure patient, method for discrimination of cardiac disease, test reagent for cardiac failure, test kit for cardiac failure, device for detecting cardiac failure, and program for detecting cardiac failure
EP3360570A1 (de) 2017-02-13 2018-08-15 Roche Diagnostics GmbH Monoklonale antikörper für nt-probnp punktmutationen
JP7203034B2 (ja) * 2017-10-02 2023-01-12 大塚製薬株式会社 アナライトの検出方法
CN108752480B (zh) * 2018-05-30 2022-03-29 中元汇吉生物技术股份有限公司 一种免疫原组合物、其制备方法及其用途
US11931207B2 (en) 2018-12-11 2024-03-19 Eko.Ai Pte. Ltd. Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device
US11446009B2 (en) 2018-12-11 2022-09-20 Eko.Ai Pte. Ltd. Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images
CN111487222B (zh) * 2019-01-28 2023-11-14 上海乐合生物科技有限公司 一种检测bnp的spr芯片的制备方法
EP4014041A1 (de) 2019-08-13 2022-06-22 Gentian AS Hochempfindliches partikelverstärktes assay zur quantifizierung von nt-probnp
EP4222499A1 (de) 2020-09-30 2023-08-09 F. Hoffmann-La Roche AG Zirkulierendes total-nt-probnp (glycosyliertes und unglycosyliertes nt-probnp) und sein verhältnis mit nt-probnp (unglycosyliertem nt-probnp) bei der beurteilung von vorhofflimmern
CN112986586A (zh) * 2021-02-20 2021-06-18 广东菲鹏生物有限公司 一种氨基末端脑尿钠肽检测方法和试剂盒
CN112964885B (zh) * 2021-02-20 2022-11-11 广东菲鹏生物有限公司 一种氨基末端脑尿钠肽检测方法和试剂盒
WO2023052642A1 (en) 2021-10-01 2023-04-06 Gentian As Novel method for determining a concentration of n-terminal pro-hormone bnp (nt-probnp) in a sample
WO2023175152A1 (en) 2022-03-18 2023-09-21 Roche Diagnostics Gmbh Troponin marker combinations for early discrimination of type 2 versus type 1 acute myocardial infarction
WO2023175176A1 (en) 2022-03-18 2023-09-21 Roche Diagnostics Gmbh Cmybpc marker combinations for early discrimination of type 2 versus type 1 acute myocardial infarction

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3445816C1 (de) 1984-12-15 1986-06-12 Behringwerke Ag, 3550 Marburg Flaechenfoermiges diagnostisches Mittel
JP2665850B2 (ja) 1991-11-14 1997-10-22 塩野義製薬株式会社 hBNPのC端を認識するモノクロ−ナル抗体
GB9211686D0 (en) 1992-06-03 1992-07-15 Medisinsk Innovation A S Chemical compounds
GB9827348D0 (en) * 1998-12-12 1999-02-03 Univ Leicester Natriuretic peptide
DE50015291D1 (de) * 1999-01-29 2008-09-11 Roche Diagnostics Gmbh Verfahren zum Nachweis von N-terminalem proBNP
US20030219734A1 (en) 2001-04-13 2003-11-27 Biosite Incorporated Polypeptides related to natriuretic peptides and methods of their identification and use
US20040096919A1 (en) * 2002-11-18 2004-05-20 Michelle Davey Polyclonal-monoclonal ELISA assay for detecting N-terminus proBNP
ATE522546T1 (de) * 2003-05-12 2011-09-15 Hoffmann La Roche Verfahren zum nachweis von probnp mit einem monoklonalen antikörper, der die amino saüre 38- 43 bindet

Also Published As

Publication number Publication date
ES2369008T3 (es) 2011-11-24
ES2372282T3 (es) 2012-01-18
EP2949669A1 (de) 2015-12-02
CA2522747A1 (en) 2004-11-18
EP1625163B1 (de) 2011-08-31
BRPI0410261B1 (pt) 2020-03-10
JP2007535470A (ja) 2007-12-06
JP5128125B2 (ja) 2013-01-23
ATE517124T1 (de) 2011-08-15
JP4430066B2 (ja) 2010-03-10
PL1625163T3 (pl) 2012-01-31
US7811770B2 (en) 2010-10-12
CN1832964A (zh) 2006-09-13
US7264939B2 (en) 2007-09-04
HUE025169T2 (en) 2016-02-29
DK1625163T3 (da) 2011-12-05
US20060110775A1 (en) 2006-05-25
KR20080011467A (ko) 2008-02-04
CA2522378C (en) 2011-03-29
EP2256132B1 (de) 2015-04-01
EP1625163A1 (de) 2006-02-15
DK2256132T3 (en) 2015-07-13
BRPI0410261B8 (pt) 2021-07-27
JP2010011860A (ja) 2010-01-21
JP2013018784A (ja) 2013-01-31
EP1625163B8 (de) 2011-11-02
US20070099241A1 (en) 2007-05-03
CA2522747C (en) 2012-08-14
AU2004235974B2 (en) 2008-02-14
CN101967190A (zh) 2011-02-09
CN1784425A (zh) 2006-06-07
EP2256132A1 (de) 2010-12-01
KR100857752B1 (ko) 2008-09-11
EP1625164B1 (de) 2011-07-20
CN100497393C (zh) 2009-06-10
JP2007525427A (ja) 2007-09-06
EP1625164A1 (de) 2006-02-15
WO2004099252A1 (en) 2004-11-18
US20070117156A1 (en) 2007-05-24
CA2522378A1 (en) 2004-11-18
BRPI0410261A (pt) 2006-05-16
ES2548327T3 (es) 2015-10-15
KR20060003905A (ko) 2006-01-11
WO2004099253A1 (en) 2004-11-18
PL2256132T3 (pl) 2016-08-31
PL1625164T3 (pl) 2011-12-30
DK1625164T3 (da) 2011-10-31
JP4834136B2 (ja) 2011-12-14
US7807380B2 (en) 2010-10-05
US7264938B2 (en) 2007-09-04
HK1097855A1 (en) 2007-07-06
AU2004235974A1 (en) 2004-11-18
JP5649631B2 (ja) 2015-01-07
US20060110776A1 (en) 2006-05-25
MXPA05011826A (es) 2006-01-26

Similar Documents

Publication Publication Date Title
ATE522546T1 (de) Verfahren zum nachweis von probnp mit einem monoklonalen antikörper, der die amino saüre 38- 43 bindet
PE20090722A1 (es) Hepcidina, antagonistas de la hepcidina y metodos de uso
ATE480562T1 (de) Veränderung von fcrn-bindungsaffinitäten oder von serumhalbwertszeiten von antikörpern mittels mutagenese
RS54113B1 (en) COMPOSITIONS AND PROCEDURES FOR ANTIBODIES ON THE C5 COMPLEMENTARY PROTEIN
ATE440868T1 (de) Monoklonaler antikírper gegen ein prion protein und dessen verwendung zum nachweis von prionen
ATE554106T1 (de) Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung
DE50014666D1 (de) VERFAHREN ZUM NACHWEIS VON N-TERMINALEM proBNP
DE602004001533D1 (de) Immunotestverfahren für Herz-Troponin I
RU2010133547A (ru) Анти-cldn антитела
DE60334696D1 (de) Antikörper, die spezifische für probnp(1-108) sind, und ihre verwendung zur diagnose von herzinfarkt
ATE554390T1 (de) Verfahren zur gewinnung von antikörpern
ATE523523T1 (de) Monoklonale anti minichomosome maintenance 2 protein antikörper und verfahren zu deren verwendung beim nachweis einer zervikalen erkrankung
DE50304608D1 (de) Sandwich-immunoassay zur bestimmung von proanp-teilpeptiden
DE60014124D1 (de) Antikörper, die spezifisch für fullerene sind
ATE511650T1 (de) Verfahren zum nachweis von antikörpern einer bestimmten klasse über einen immunkomplex spezifischen antikörper
ATE513215T1 (de) Monoklonale antikörper, hybridomzellinien, verfahren und kits zum nachweis von phytase
ATE535546T1 (de) Humane monoklonale antikörper, die spezifisch an ifg-ii binden
JP3996137B2 (ja) 抗重金属モノクローナル抗体およびその使用方法
WO2009044561A1 (ja) 抗proNT/NMNモノクローナル抗体
WO2009016734A1 (ja) 軽度認知機能障害の検定方法
SE0202702L (sv) Immunotest för specifik bestämning av SCCA isoformer
DE69919859D1 (de) Verfahren zum bestimmen eines überschäumfaktors für ein getränk
PE20191840A1 (es) Kit diagnostico diferencial y rapido para deteccion de la coriza infecciosa y el sindrome de cabeza hinchada en la industria avicola
ATE111226T1 (de) Verfahren zum nachweis von analyten.
ATE405646T1 (de) Ein verfahren zum auffinden vom prostatakrebs

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1625163

Country of ref document: EP